COCRYSTAL PHARMA, INC. Depreciation Expense (Deprecated 2009-01-31)
COCRYSTAL PHARMA, INC. (COCP) reported Depreciation Expense (Deprecated 2009-01-31) of $85.24 thousand for the 3-month period ending 2011-06-30, per its 10-Q/A filed 2011-09-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationExpense · last filed 2011-09-09
- COCRYSTAL PHARMA, INC. depreciation expense (deprecated 2009-01-31) for the quarter ending 2011-06-30 was $85.24K, a 5.42% increase year-over-year.
- COCRYSTAL PHARMA, INC. depreciation expense (deprecated 2009-01-31) for the quarter ending 2010-06-30 was $80.86K.
| Period end | Depreciation Expense (Deprecated 2009-01-31) 3 month | Depreciation Expense (Deprecated 2009-01-31) 6 month |
|---|---|---|
| 2011-06-30 | $85.24K 10-Q/A · filed 2011-09-09 | $166.65K 10-Q/A · filed 2011-09-09 |
| 2010-06-30 | $80.86K 10-Q/A · filed 2011-09-09 | $161.61K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |